← Back to Search

Cognitive Behavioral Therapy

Cognitive Behavioural Therapy for Postpartum Depression

N/A
Waitlist Available
Led By Ryan Van Lieshout, MD, PHD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Infants must be between 4-12 months old at enrollment
Meets diagnostic criteria for comorbid psychiatric conditions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will study whether online group CBT for maternal postpartum depression leads to greater improvements in infant emotion regulation than treatment as usual.

Who is the study for?
This trial is for English-speaking women over 18 living in Ontario with postpartum depression, as indicated by an EPDS score of at least 10. Their infants should be aged between 4-8 months. Women with bipolar disorder, current psychotic disorders, substance abuse issues, or certain personality disorders cannot participate.
What is being tested?
The study tests if adding online group cognitive behavioral therapy (CBT) to the usual treatment helps improve how babies manage their emotions better than just the usual treatment alone. The effects will be checked right after and six months post-treatment.
What are the potential side effects?
Since this trial involves psychological therapy rather than medication, typical side effects associated with drugs are not expected. However, participants may experience emotional discomfort discussing personal topics during CBT sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My infant is between 4 to 12 months old.
Select...
I have been diagnosed with a mental health condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Infant Temperament
Infant emotion regulation
Maternal Anxiety
+1 more
Secondary study objectives
Brain-to-brain Synchrony (fNIRS)
Epigenetic Analyses
Parent-Child Early Relational Assessment (PCERA)
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment (9-week online CBT group)Experimental Treatment1 Intervention
Participants assigned to the treatment group will continue to receive any healthcare they might already be receiving (e.g. family doctor, midwife, Obstetrician/Gynecologist, etc.) and participate in a 9-week group Cognitive Behavioral Therapy (CBT) intervention for Postpartum Depression (PPD) delivered via Zoom by two trained psychologists, social workers, nurses, and/or psychiatrists.
Group II: Control (treatment as usual)Active Control1 Intervention
The control group will receive standard postnatal care from their obstetrician, midwife, and/or family physician
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Group Cognitive Behavioural Therapy (CBT)
2020
N/A
~160

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
918 Previous Clinical Trials
2,616,121 Total Patients Enrolled
13 Trials studying Postpartum Depression
3,154 Patients Enrolled for Postpartum Depression
Ryan Van Lieshout, MD, PHDPrincipal InvestigatorMcmaster

Media Library

Group Cognitive Behavioural Therapy (CBT) (Cognitive Behavioral Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05269732 — N/A
Postpartum Depression Research Study Groups: Treatment (9-week online CBT group), Control (treatment as usual)
Postpartum Depression Clinical Trial 2023: Group Cognitive Behavioural Therapy (CBT) Highlights & Side Effects. Trial Name: NCT05269732 — N/A
Group Cognitive Behavioural Therapy (CBT) (Cognitive Behavioral Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05269732 — N/A
~45 spots leftby Dec 2025